New therapeutic targets to fight type 2 diabetes

[skb]

One of the most confusing aspects for patients with type 2 diabetes mellitus is that they have high fasting glucose levels. This is because in these insulin-resistant patients, glucose production by the liver is triggered, a process that is still full of questions for the scientific community. Now, a review article published in the journal Trends in Endocrinology & Metabolism presents a comprehensive overview of the most important advances in understanding this mechanism. It also helps to identify new drug targets in the fight against type 2 diabetes mellitus, which the World Health Organization (WHO) considers one of the pandemics of the 21st century.

Read More ...